Evidence Files

Vitamin C for Colds: The Nobel Laureate's Claim That Never Held Up

In 1970, a two-time Nobel laureate published a bestseller claiming megadoses of vitamin C could prevent the common cold. Fifty-plus years and thousands of trial participants later, the largest pooled analysis — nearly 10,000 cold episodes — found that regular vitamin C doesn't prevent colds in the general population at all. It does something narrower, and most people are taking it at the wrong time to get even that.

Published: 18 August 2026

Verdict

TREATMENT (partially confirmed)

We searched PubMed and Cochrane Library for vitamin C and the common cold. The Cochrane review (Hemilä & Chalker) found no reduction in cold incidence from regular supplementation in the general population — the core claim behind the entire market — with a pooled risk ratio of 0.97 across 10,708 participants. What it did find: a modest, consistent reduction in cold duration — 8% in adults and 14% in children — but only with daily use started before the cold. In seven comparisons covering 3,249 episodes where vitamin C was begun after symptoms appeared, there was no consistent effect at all. And one genuine outlier: among marathon runners, skiers and soldiers on subarctic exercises, cold incidence roughly halved.

Why Europe still stocks up every winter

The claim traces back to one man: Linus Pauling, who had already won a Nobel Prize in Chemistry (and would later win the Peace Prize) when he published "Vitamin C and the Common Cold" in 1970. He was not a physician, an immunologist, or a clinical researcher — but the Nobel-laureate label carried enormous authority, and the public didn't distinguish between winning a prize in chemistry and having evidence in medicine.

The claim arrived at the perfect moment: cheap, unpatentable, sold over the counter, requiring no doctor's involvement. Effervescent vitamin C tablets became a fixture of European pharmacy shelves every September, marketed as immune "support" and cold "defence" — vague enough to avoid regulatory scrutiny, specific enough to imply Pauling's original claim.

Five decades of trials followed, largely because the claim was cheap to test and impossible for the supplement industry to let go of. The evidence that accumulated is more interesting — and more limited — than either Pauling's original claim or the industry that grew around it.

What the science actually says

The Cochrane data are detailed enough to answer not just "does it work" but for whom, and when.

No reduction in cold incidence in the general population. This is the core Pauling claim, and it is the one that failed: across 10,708 participants the pooled risk ratio was 0.97 (95% CI 0.94–1.00). In plain terms, no difference
A modest, consistent reduction in duration. Thirty-one comparisons covering 9,745 cold episodes: colds ran 8% shorter in adults and 14% shorter in children. For a typical seven-day cold, 8% is around fourteen hours. In children taking 1–2 g/day the reduction reached 18%
Timing matters, and most people get it wrong. In seven comparisons across 3,249 episodes where vitamin C was started only after symptoms appeared — therapeutic use, which is exactly how most people take it — there was no consistent effect on either duration or severity
A genuinely large effect exists, in one narrow group. Five trials, 598 participants under short bouts of extreme physical or cold stress — marathon runners, skiers, soldiers on subarctic exercises — produced a risk ratio of 0.48: cold incidence roughly halved
The reviewers leave room for a personal experiment. They note that given vitamin C's low cost and safety, it may be worth an individual patient testing whether therapeutic use helps them specifically. An honest position — but one about trying, not about demonstrated effect
Pauling's own supporting trials were weak — small, poorly controlled by modern standards, and the effect sizes he championed were not replicated by the much larger, better-designed trials that came after

What the label claims vs. what the evidence shows

Common marketing claims

"Supports your immune defences." "Helps fight colds." Sold in tubes of effervescent tablets every autumn across German, French, and UK pharmacy chains, often at 1,000mg per dose — implying prevention for anyone who takes it, taken any time, including once symptoms appear.

What the evidence shows

No prevention effect for the general population, regardless of when you start — risk ratio 0.97. A modest cut in how long a cold lasts, 8% in adults, but only if you were already supplementing daily before you got sick. A real prevention effect under extreme physical exertion or cold exposure — not everyday winter life.

Frequently asked questions

Does vitamin C help if I start taking it when symptoms begin?

On the available evidence, no. The Cochrane review analysed seven comparisons across 3,249 cold episodes in which vitamin C was started after symptoms appeared, and found no consistent effect on duration or severity. The benefit only appears when supplementation was already running before the cold began — which is the opposite of how most people use it.

Does vitamin C prevent colds?

Not in ordinary people. Across 10,708 participants, regular supplementation produced a risk ratio of 0.97 — effectively no difference. The exception is people under short bouts of extreme physical stress in the cold: marathon runners, skiers and soldiers on subarctic exercises had roughly half the cold incidence, a genuinely large effect in a narrowly defined group.

How much should I give a child?

Start by recalibrating what it does: the effect is on duration, not on whether they catch a cold, and it is about 14%. In trials where children took 1–2 g/day the reduction was larger, 18%. But that means daily supplementation through the season rather than a few tablets during illness, and the dose for a particular child is worth agreeing with a paediatrician.

Are high doses — 1,000 mg and up — harmful?

Vitamin C is water-soluble and excess is largely excreted, which is why it carries a harmless reputation. Large doses can still cause gastrointestinal upset, and in susceptible people may contribute to oxalate kidney stones. "More" clearly doesn't mean "better" here: the trial effects did not scale up proportionally with dose.

So is it worth taking at all?

It can be, provided you know what you're buying. It is cheap, safe, and has a real if small effect with daily use — and the reviewers themselves suggest an individual may reasonably test whether it helps them. What it won't do is prevent the cold, or rescue one that has already started. For a cold already underway, symptomatic relief has better support in adults and older children, though the same review notes there is no evidence of benefit in young children.

Our Conclusion

Vitamin C is not the general-purpose cold-prevention supplement its market position implies, and reaching for it once your throat feels scratchy is, per the evidence, close to pointless — that ship has sailed. If you already take it daily through the winter, the honest expectation is a modestly shorter cold, not a cold you never get. If you're a marathon runner, skier, or otherwise regularly pushing your body to extremes in the cold, the evidence for prevention is genuinely strong and worth acting on. For everyone else, the extra minutes chasing effervescent tablets across pharmacy shelves buy less than the label implies.

Sources

Every claim in this article rests on a primary publication. Links go to the publisher's site or to PubMed, the US National Library of Medicine database.

This article is for informational purposes only and does not constitute medical advice. Trick or Treatment analyses the presence of clinical studies in open scientific databases — PubMed and Cochrane Library. The absence of studies in these databases does not automatically mean a drug is ineffective, but it does mean its effectiveness has not been confirmed by evidence-based medicine standards. Any treatment decisions should be made together with your doctor.